Delivery Order SPE2D020D0009-SPE2D325F0799

Award Date 10/23/24
Potential Completion Date 10/28/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $78,482.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4,561,244,124 vials of vancomycin, a critical antibiotic medication, with a performance period ending on June 6, 2023. This contract is not set aside for any specific business type. Fresenius Kabi, LLC is a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $12,220.60 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with an ultimate completion date of October 28, 2024. Fresenius Kabi is a major supplier of critical care pharmaceuticals, including injectable medications, infusion...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $3,286.92 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with a period of performance through October 28, 2024. The contract has no set-aside designation. Fresenius Kabi is a significant supplier of injectable medications...
This federal contract award is a delivery order (SPE2D020D0009|SPE2D325F0869) from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency, to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The $369,567.80 firm-fixed-price contract is for the delivery of 4,566,196,941 units of the antibiotic drug vancomycin in 1 gram vials. The contract has an ultimate completion date of October 29, 2024 and does not have a set-aside...
This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
This federal contract award is for the delivery of Doxycycline Hydrochloride Injection (10) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order with a firm fixed price of $22,035.23 and a completion date of September 27, 2024. There is no set-aside designation associated with this contract. Fresenius Kabi, LLC...
This federal contract award, valued at $1,778.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of calcium gluconate injection, a critical care pharmaceutical product, with a completion date of November 22, 2024. Fresenius Kabi is a significant supplier of injectable medications and medical solutions to federal government...
This federal contract award, SPE2D020D0009|SPE2D325F6852, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $3,632.58 firm fixed-price delivery order is for the supply of Calcium Gluconate Injection USP 100mg/mL 10mL, a critical care pharmaceutical. This order is not associated with a set-aside program. Fresenius Kabi, LLC holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,869.80 firm fixed-price delivery order is for the supply of VANCOMYCIN 1 GRAM/200 ML BAG 200ML, a critical pharmaceutical product used in medical treatment. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F0799
    Delivery Order

This federal contract award with ID SPE2D020D0009|SPE2D325F0799 was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $1,559.18, is for the delivery of Vancomycin 1 GM vials, a critical care injectable medication, to military and federal healthcare facilities. It is a firm fixed-price Delivery Order contract with an ultimate completion date of October 28, 2024.

Fresenius Kabi is a significant supplier of injectable pharmaceuticals, infusion therapies, and medical solutions to the Department of Defense and Department of Veterans Affairs. This contract is part of the company's larger indefinite delivery contract (IDV) with the VA National Acquisition Center, valued at $2.24 million over five years, to provide bortezomib, a cancer treatment drug, to multiple federal agencies. The contract does not have a set-aside designation.

Generated 1/22/25, 9:34 AM